EUVIMEDEUVIMED entdecken
LeserbriefKommentarSystematische Übersicht

In Reference to Mastoid Obliteration Decreases the Recurrent and Residual Disease: Systematic Review and Meta‐analysis

Mohammad Faramarzi iD, Ali Faramarzi iD

The Laryngoscope · 2023

DOI: 10.1002/lary.30947 ↗

Kurz gefasst

Leserbrief in der Zeitschrift The Laryngoscope, 2023. Verfasst von Mohammad Faramarzi und 1 weiteren Autor:innen. Beteiligte Einrichtung: Otolaryngology Research Center, Department of Otolaryngology, Shiraz University of Medical Sciences, Shiraz, Iran. Hauptthemen laut MEDLINE: Cholesteatoma, Middle Ear, Mastoid. Die Arbeit nennt 4 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

We recently perused, with great interest, the systematic review by Illés et al. on the effectiveness of mastoid obliteration in reducing recurrent and residual cholesteatoma incidence.1 The analysis combined studies utilizing canal wall down (CWD) or canal wall up (CWU) with obliteration and contrasted them with CWU without obliteration. Although the study's findings are certainly notable, we would like to highlight some considerations about the study's methodology that could potentially influence the interpretation and applicability of its conclusions on the effectiveness of mastoid obliteration. It is noteworthy to mention that Illés et al. did not sufficiently elaborate that the studies included on CWU with obliteration employed the bony obliteration tympanoplasty (BOT) technique. This technique involves a cortical mastoidectomy leaving the posterior canal wall intact, followed by a posterior tympanotomy and epitympanotomy, after which bone chips are utilized to isolate the epitympanum and mastoid from the middle ear.2 This procedure is generally indicated for ears with limited cholesteatoma in the epitympanum area, whereas the CWD with obliteration is indicated for ears with more extensive cholesteatoma. Consequently, grouping these distinct techniques appears inappropriate. The discrepancy in treatment indications, disease severity, and surgical techniques in the included studies might result in outcome variability, skewing perceptions of obliteration effectiveness and potentially biasing conclusions. Illés et al. merged BOT and CWD with obliteration in their analysis, focusing solely on CWU without obliteration for comparison.1 They excluded studies featuring CWD without obliteration but concluded that obliteration reduces cholesteatoma recurrence. In contrast, an earlier systematic review including 13 studies yielded the rates of recurrent and residual disease were found to be 0.28% and 4.2% respectively for CWU with obliteration, and 5.9% and 5.8% for CWD with obliteration.3 These rates are qualitatively similar to the previously reported rates for the corresponding non-obliterative CWU and CWD techniques.3, 4 Illés et al.'s exclusion of certain studies and merging of differing surgical techniques might affect the applicability of their findings. In conclusion, Illés et al.'s review pairs two heterogenous groups on one side for comparison, potentially causing outcome variability and skewed interpretations. We propose future research should contrast each obliterative technique with its non-obliterative counterpart, specifically CWD with obliteration vs. CWD without obliteration and CWU with obliteration vs. CWU without obliteration. This would provide a more accurate assessment of mastoid obliteration's role in managing cholesteatoma.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cholesteatoma, Middle EarMastoidHumansMastoidectomyNeoplasm Recurrence, LocalRetrospective StudiesTreatment OutcomeTympanoplasty

Autor:innen und Institutionen

  • Otolaryngology Research Center, Department of Otolaryngology, Shiraz University of Medical Sciences, Shiraz, Iran.
  • Student Research Committee, Shiraz University of Medical Sciences, Shiraz, Iran.

ORCID-Profile: Mohammad Faramarzi, Ali Faramarzi

Zitieren

APA

Faramarzi, M., & Faramarzi, A. (2023). In Reference to Mastoid Obliteration Decreases the Recurrent and Residual Disease: Systematic Review and Meta‐analysis. The Laryngoscope. https://doi.org/10.1002/lary.30947

Vancouver

Faramarzi M, Faramarzi A. In Reference to Mastoid Obliteration Decreases the Recurrent and Residual Disease: Systematic Review and Meta‐analysis. The Laryngoscope. 2023. doi:10.1002/lary.30947

BibTeX
@article{Faramarzi2023,
  author = {Faramarzi, Mohammad and Faramarzi, Ali},
  title = {In Reference to Mastoid Obliteration Decreases the Recurrent and Residual Disease: Systematic Review and Meta‐analysis},
  journal = {The Laryngoscope},
  year = {2023},
  doi = {10.1002/lary.30947}
}
Kostenlos starten →